-
Mashup Score: 1PROTAC Targeting LZK Shows Promise for Treating HNSCC - NCI Center for Cancer Research - OncoDaily - 26 day(s) ago
PROTAC Targeting LZK Shows Promise for Treating HNSCC – NCI Center for Cancer Research / Amy L Funk, Anna A Marusiak, cancer, Carolyn C Woodroofe, head and
Source: oncodaily.comCategories: General Medicine NewsTweet
-
Mashup Score: 4Vivek Subbiah: Sharing the Key Advances in Oncology and Exciting Publications from ASCO25 - OncoDaily - 1 month(s) ago
Vivek Subbiah: Sharing the Key Advances in Oncology and Exciting Publications from ASCO25 / Annals of Oncology, ASCO25, C. Ola Landgren, cancer, CAR T-cell
Source: oncodaily.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
The public should adopt the “wet-bulb globe temperature.”
Source: www.washingtonpost.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
The conspiracy theories about Joe Biden’s diagnosis perpetuate harmful myths.
Source: www.washingtonpost.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
First-line therapy for advanced non–small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportion score for programmed death …
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 3American Cancer Society Cancer Action Network - 2 month(s) ago
ACS CAN is the nation’s leading cancer advocacy organization that is working every day to make cancer issues a national priority.
Source: www.fightcancer.orgCategories: General Medicine NewsTweet
-
Mashup Score: 17
Interleukin-10 (IL-10) presents a dual role in systemic lupus erythematosus (SLE), illustrating pro-inflammatory and anti-inflammatory effects. This study addressed the possible associations between serum IL-10 levels and demographic characteristics, laboratory parameters, organ manifestations, disease activity, and treatment response in SLE patients. A total of 88 SLE patients from the Rheumatology Clinic of the Clinical Rehabilitation Hospital, Iași, were enrolled. Disease activity was assessed using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Serum cytokine levels were measured using an enzyme-linked immunosorbent assay (ELISA). Serum IL-10 levels were significantly higher in males compared to females (47.62 pg/mL vs. 13.24 pg/mL, p = 0.011) but not significantly associated with age or disease duration. However, IL-10 showed positive correlations with inflammatory markers and autoantibodies, including C-reactive protein (p = 0.002), IL-6 (p = 0.01), ANA (p = 0.
Source: www.mdpi.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Desmoplastic Melanoma: 5-Minute Pathology Pearls - 3 month(s) ago
A complete organized library of all my videos, digital slides, pics, & sample pathology reports is available here: https://kikoxp.com/posts/5084 (dermpath) &…
Source: www.youtube.comCategories: General Medicine NewsTweet
-
Mashup Score: 3More Everything Forever: AI Overlords, Space Empires, and Silicon Valley's Crusade to Control the Fate of Humanity - 3 month(s) ago
Tech billionaires have decided that they should determine our futures for us. According to Elon Musk, Jeff Bezos, Sam Altman, and more, the only good future for humanity is one powered by technology: trillions of humans living in space, functionally immortal, served by superintelligent AIs. …
Source: www.amazon.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Frontiers | Keloids and inflammation: the crucial role of IL-33 in epidermal changes - 3 month(s) ago
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Introduction: Keloids are benign fibroproliferative disorders characterized by excessive collagen deposition and inflammation that extend beyond the original wound boundaries. IL-33 is an alarmin cytokine released upon cellular damage or stress. Dysregulation of IL-33 in epidermal keratinocytes compromises the skin barrier and triggers chronic inflammation.
Source: www.frontiersin.orgCategories: General Medicine NewsTweet
RT @oncodaily: NCI Center for Cancer Research - PROTAC Targeting LZK Shows Promise for Treating HNSCC @theNCI https://t.co/hfRWZIogXP #O…